BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
Rahul Roychoudhuri(University of Cambridge), Nicholas P. Restifo(Lyell Immunopharma (United States))
Cited by 329
Related Papers
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
|Nature Clinical Practice Oncology|2006|348
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection
|The Journal of Experimental Medicine|2015|258